An analysis of the SWOG S0221 trial published by Chen et al in JNCCN—Journal of the National Comprehensive Cancer Network
aimed to validate potential risk factors for chemotherapy-induced peripheral neuropathy in patients receiving paclitaxel.
Question 1 of 5
The objective of this study was to validate pretreatment ___ as a risk factor for chemotherapy-induced peripheral neuropathy in patients with early-stage breast cancer.
